GlassScriptPrepare for your visit
Jeralynn Sheets
Family · Grove City, OH · NPI 1487356622
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,290.64
in general payments reported to CMS, 2019-2025 · $661 in 2025
The $661 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Astrazeneca Pharmaceuticals LP $393.54
- Abbvie INC. $243.68
- Abbott Laboratories $165.29
- Lilly USA, LLC $162.97
- Exact Sciences Corporation $159.46
- Dexcom, INC. $121.08
Drugs and devices associated with these payments
Farxiga Freestyle Libre 3 Breztri Cologuard Collection Kit Airsupra Dexcom G6 Transmitter Xifaxan Mounjaro Repatha Vraylar Linzess Kerendia
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Jeralynn Sheets listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11524459/jeralynn-sheets